AGYTF Stock - Allergy Therapeutics plc
Unlock GoAI Insights for AGYTF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $75.56M | $55.20M | $59.59M | $72.77M | $84.33M |
| Gross Profit | $34.50M | $29.74M | $33.24M | $49.51M | $62.23M |
| Gross Margin | 45.7% | 53.9% | 55.8% | 68.0% | 73.8% |
| Operating Income | $-28,162,000 | $-35,257,000 | $-39,654,000 | $-12,245,000 | $4.03M |
| Net Income | $-55,093,209 | $-40,216,000 | $-43,071,000 | $-13,776,000 | $2.89M |
| Net Margin | -72.9% | -72.9% | -72.3% | -18.9% | 3.4% |
| EPS | $-0.01 | $-0.01 | $-0.04 | $-0.01 | $0.00 |
Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Penicillin diagnostics, Pollinex, and VLP Peanut. The company also develops allergy vaccines for trees, grass, house dust mite, and pets with fur/hair, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.
Visit WebsiteEarnings History & Surprises
AGYTFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 30, 2026 | — | — | — | — |
Q1 2025 | Mar 31, 2025 | — | $-0.00 | — | — |
Q4 2024 | Nov 6, 2024 | $-0.01 | $-0.01 | +0.8% | ✓ BEAT |
Q1 2024 | Mar 27, 2024 | — | $-0.01 | — | — |
Q2 2023 | Jun 30, 2023 | $-0.01 | $-0.03 | -153.8% | ✗ MISS |
Q4 2022 | Dec 31, 2022 | $-0.01 | $-0.01 | -30.5% | ✗ MISS |
Q2 2022 | Jun 30, 2022 | $-0.01 | $-0.02 | -72.0% | ✗ MISS |
Q4 2021 | Dec 31, 2021 | — | $0.01 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.01 | — | — |
Q4 2020 | Dec 31, 2020 | — | $0.01 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.01 | — | — |
Q4 2019 | Dec 31, 2019 | — | $0.01 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.01 | — | — |
Q4 2018 | Dec 31, 2018 | — | $0.01 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-0.01 | — | — |
Q4 2017 | Dec 31, 2017 | — | $0.01 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-0.01 | — | — |
Q4 2016 | Dec 31, 2016 | — | $0.01 | — | — |
Q2 2016 | Jun 30, 2016 | — | $-0.01 | — | — |
Q4 2015 | Dec 31, 2015 | — | $0.00 | — | — |
Latest News
Frequently Asked Questions about AGYTF
What is AGYTF's current stock price?
What is the analyst price target for AGYTF?
What sector is Allergy Therapeutics plc in?
What is AGYTF's market cap?
Does AGYTF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to AGYTF for comparison